Graft-versus-Host disease Prophylaxis with Everolimus and Tacrolimus Is Associated with a High Incidence of Sinusoidal Obstruction Syndrome and Microangiopathy: Results of the EVTAC Trial-Reference-Cited by-同舟云学术

Graft-versus-Host disease Prophylaxis with Everolimus and Tacrolimus Is Associated with a High Incidence of Sinusoidal Obstruction Syndrome and Microangiopathy: Results of the EVTAC Trial

Published:2009-01 Issue:1 Volume:15 Page:101-108
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Platzbecker Uwe,von Bonin Malte,Goekkurt Eray,Radke Jörgen,Binder Marc,Kiani Alexander,Stoehlmacher Jan,Schetelig Johannes,Thiede Christian,Ehninger Gerhard,Bornhäuser Martin

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference48 articles.

1. Graft-versus-host disease;Platzbecker,2004

2. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia;Gratwohl;Blood,2002

3. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med. 314:729–735.

4. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors;Nash;Blood,2000

5. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation;Przepiorka;Blood,1996

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplant-Cyclophosphamide and short-term Everolimus as Graft-versus-Host-Prophylaxis in a real –world cohort of patients with refractory T- and B-cell Lymphoma;2024-08-17

2. Transplant-associated thrombotic microangiopathy in pediatrics: incidence, risk factors, therapeutic options, and outcome based on data from a single center;Frontiers in Oncology;2024-07-10

3. Post‐transplant‐cyclophosphamide and short‐term Everolimus as graft‐versus‐host‐prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET‐EVER trial;European Journal of Haematology;2024-04-14

4. Everolimus and mycophenolate mofetil effectively prevent GvHD in children with severe acute kidney injury undergoing allogeneic HSCT;2024-03-16

5. Ultrasonographic scoring system of late-onset sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation;Bone Marrow Transplantation;2022-05-25